Showing results (31-40 of 67) with videos related to

Sort By:
Pageof 7
International Journal of Cancer|January 24, 2023
Molnupiravir is effective in patients with haematological malignanciesŁukasz Bołkun, Bartosz Pula, Agnieszka Kołkowska-Leśniak, et al.
Chemotherapy|March 6, 2022
Rituximab and Chemotherapy for Newly Diagnosed Follicular Lymphoma: Real-World Report of Polish Lymphoma Research GroupEwa Paszkiewicz-Kozik, Malgorzata Debowska, Natalia Jakacka, et al.
Chemotherapy|January 25, 2014
Bendamustine as monotherapy and in combination regimens for the treatment of chronic lymphocytic leukemia and non-hodgkin lymphoma: a retrospective analysisIwona Hus, Dariusz Jawniak, Magdalena Gorska-Kosicka, et al.
Frontiers in Immunology|March 17, 2022
A Specific CD44lo CD25lo Subpopulation of Regulatory T Cells Inhibits Anti-Leukemic Immune Response and Promotes the Progression in a Mouse Model of Chronic Lymphocytic LeukemiaAgnieszka Goral, Malgorzata Firczuk, Klaudyna Fidyt, et al.
British Journal of Haematology|December 16, 2016
Randomized phase 2 study of otlertuzumab and bendamustine versus bendamustine in patients with relapsed chronic lymphocytic leukaemiaTadeusz Robak, Andrzej Hellmann, Janusz Kloczko, et al.
Leukemia|July 22, 2022
Overall survival in the SIMPLIFY-1 and SIMPLIFY-2 phase 3 trials of momelotinib in patients with myelofibrosisRuben Mesa, Claire Harrison, Stephen T Oh, et al.
Oncoimmunology|May 4, 2018
FOXO1 promotes resistance of non-Hodgkin lymphomas to anti-CD20-based therapyBeata Pyrzynska, Michal Dwojak, Abdessamad Zerrouqi, et al.
Oncogene|January 29, 2022
Potent, p53-independent induction of NOXA sensitizes MLL-rearranged B-cell acute lymphoblastic leukemia cells to venetoclaxKlaudyna Fidyt, Agata Pastorczak, Julia Cyran, et al.
Leukemia|April 4, 2025
LILRB1-directed CAR-T cells for the treatment of hematological malignanciesKatsiaryna Marhelava, Klaudyna Fidyt, Monika Pepek, et al.
Leukemia & Lymphoma|June 1, 2013
Long-term results of the Polish Adult Leukemia Group PALG-CLL2 phase III randomized study comparing cladribine-based combinations in chronic lymphocytic leukemiaTadeusz Robak, Jerzy Z Blonski, Joanna Gora-Tybor, et al.
Pageof 7